Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands

Bart P. H. Slob*, Maarten J. Postma, Maaike Weersma, Hans-Peter Brunner-La Rocca, Lisa A. de Jong, Cornelis Boersma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages12
JournalAmerican Journal of Cardiovascular Drugs
DOIs
Publication statusE-pub ahead of print - 12 Jul 2025

Cite this